Press releaseGlobe Newswire
Rafael Holdings
RFL · NYSE
$1.29+$0.00 (+0.00%)TodayMarket closed ·
Prev close $1.29
Latest news
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
- NewsAvi Kapoor
Crude Oil Rises Over 1%; Conagra Brands Earnings Top Views
- NewsVandana Singh
Why Is Rafael Stock Falling Wednesday?
- News
Rafael Holdings Announced Topline Efficacy And Safety Data From Its Cyclo Therapeutics Subsidiary’s Phase 3 TransportNPC Study Evaluating Trappsol Cyclo In 94 Patients Diagnosed With Niemann-Pick Disease Type C; Trappsol Cyclo Did Not Achieve Statistical Significance
- Press releaseGlobe Newswire
Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseGlobe Newswire
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
- Press releaseGlobe Newswire
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
- Press releaseGlobe Newswire
Rafael Holdings Announces Patent Licensing Agreement with MIT for "Small Molecules to Improve Myelination in ApoE4 positive Alzheimer's Disease"
- Press releaseGlobe Newswire
Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- Press releaseGlobe Newswire
Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results
- Press releaseGlobe Newswire
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseBusiness Wire
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH
- Press releasePRNewswire
Kuehn Law Encourages CDE, SMC, COFS, and RFL Investors to Contact Law Firm
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FYBR, COFS, RFL on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMAR, MNTX, RFL on Behalf of Shareholders
- Press releasePRNewswire
Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, GATO, RFL on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of RFL, PORT and MNTX
- Press releasePRNewswire
Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHEB, ARC, RFL on Behalf of Shareholders
- NewsAvi Kapoor
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
- Press releaseBusiness Wire
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH
- Press releaseBusiness Wire
RFL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Rafael Holdings, Inc. Is Fair to Shareholders
- Press releaseBusiness Wire
Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.